Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
8.94
-0.30 (-3.25%)
At close: May 09, 2025, 3:59 PM
8.95
0.11%
After-hours: May 09, 2025, 04:55 PM EDT
Company Description
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging.
The Company leads research on nicotinamide adenine dinucleotide.
Niagen Bioscience Inc
| Country | United States |
| IPO Date | Jun 24, 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 104 |
| CEO | Robert N. Fried |
Contact Details
Address: 10900 Wilshire Blvd, Suite 600 Los Angeles, California United States | |
| Website | https://www.niagenbioscience.com/ |
Stock Details
| Ticker Symbol | NAGE |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 171077407 |
| ISIN Number | US1710774076 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Robert N. Fried | Chief Executive Officer & Director |
| Michiko Kelley | Chief Marketing Officer |
| Ozan Pamir C.F.A. | Chief Financial Officer & Principal Accounting Officer |
| Carlos Lopez | Senior Vice President & General Counsel |
| Chu Yan | Managing Director of Asia Pacific |
| Dr. Andrew Shao Ph.D. | Senior Vice President of Global Regulatory & Scientific Affairs |
| Frank Louis Jaksch Jr. | Co-Founder & Chairman |
| James Lee | Controller |
| Kendall Knysch | Head of Media Relations & Partnerships |